* Imunon Inc IMNN.OQ IMNN.O is expected to show a fall
in
quarterly revenue when it reports results on March 28 for the
period ending December 31 2023
*
* LSEG's mean analyst estimate for Imunon Inc is for a loss
of 41
cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Imunon Inc
is
$12.00, above its last closing price of $0.90.
This summary was machine generated March 26 at 12:40 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)